The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Schizophrenia
Abstract
Schizophrenia has varied and ominous symptoms that generally begin in late adolescence or early adulthood and usually continue throughout life. This Drug Therapy article discusses the new generation of antipsychotic medications, as well as recent developments in brain imaging and in knowledge of the pathophysiology and molecular genetics of this devastating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393
McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.921 · Cited by 1,056
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020
Selemon, L. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950220015005 · Cited by 876
Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341750 · Cited by 856
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., La Rosa, P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412499 · Cited by 829
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Thompson, P. M., Vidal, C., Giedd, J. N., Gochman, P., Blumenthal, J., Nicolson, R., Toga, A. W., & Rapoport, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201243998 · Cited by 812
Tran, P. V., Hamilton, S. H., Kuntz, A. J., Potvin, J. H., Andersen, S. W., Beasley, C. J., & Tollefson, G. D. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199710000-00010 · Cited by 715
Keefe, R. S. E., Silva, S. G., Perkins, D. O., & Lieberman, J. A. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033374 · Cited by 693
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Kane, J. M., Carson, W. H., Saha, A. R., McQuade, R. D., Ingenito, G. G., Zimbroff, D. L., & Ali, M. W. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0903 · Cited by 624
Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia
Sernyak, M. J., Leslie, D. L., Alarcon, R. D., Losonczy, M. F., & Rosenheck, R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.561 · Cited by 623
Csernansky, J. G., Mahmoud, R., & Brenner, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa002028 · Cited by 605
Meltzer, H. Y. (1989) · Psychopharmacology · doi:10.1007/bf00442554 · Cited by 602
Schizophrenia: genes and environment
Tsuang, M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00289-9 · Cited by 597
Drug and Sociotherapy in the Aftercare of Schizophrenic Patients: II. Two-Year Relapse Rates
Hogarty, G. E. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760170005001 · Cited by 573
Tamminga, C. A. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070016003 · Cited by 547
Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J., Kunz, M., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1018 · Cited by 538
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529
Neuroleptic malignant syndrome
Caroff, S. N., & Mann, S. C. (1993) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30278-4 · Cited by 514
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
Jordan, S., Koprivica, V., Chen, R., Tottori, K., Kikuchi, T., & Altar, C. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01532-7 · Cited by 512
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
CARLSSON, A. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.2.164 · Cited by 498
Quetiapine in Patients With Schizophrenia: A High- and Low-Dose Double-blind Comparison With Placebo
Small, J. G. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180067009 · Cited by 478
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00138-3 · Cited by 470
Amisulpride, an Unusual “Atypical” Antipsychotic: A Meta-Analysis of Randomized Controlled Trials
Leucht, S., Pitschel-Walz, G., Engel, R. R., & Kissling, W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.180 · Cited by 470
Lindenmayer, J.-P., Czobor, P., Volavka, J., Citrome, L., Sheitman, B., McEvoy, J. P., Cooper, T. B., Chakos, M., & Lieberman, J. A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.290 · Cited by 465
Leonard, S., Gault, J., Hopkins, J., Logel, J., Vianzon, R., Short, M., Drebing, C., Berger, R., Venn, D., Sirota, P., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1085 · Cited by 441
Self-citationHippocampal Pathologic Findings in Schizophrenia: A Morphometric Study
Jeste, D. V. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110061009 · Cited by 429
Siris, S. G. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500209 · Cited by 412
A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia
Woo, T.-U., Whitehead, R. E., Melchitzky, D. S., & Lewis, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5341 · Cited by 410
Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J. P., Cooper, T. B., Chakos, M., & Lieberman, J. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.255 · Cited by 407
Castner, S. A., Williams, G. V., & Goldman-Rakic, P. S. (2000) · Science · doi:10.1126/science.287.5460.2020 · Cited by 401
Akbarian, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050061010 · Cited by 397
Spatial Working Memory Deficits in the Relatives of Schizophrenic Patients
Park, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950220031007 · Cited by 378
Daniel, D. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00090-6 · Cited by 377
Association and linkage analyses of RGS4 polymorphisms in schizophrenia
Chowdari, K. V. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.12.1373 · Cited by 368
Hogarty, G. E. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780120013001 · Cited by 365
Voxel-Based Morphometric Analysis of Gray Matter in First Episode Schizophrenia
Kubicki, M. (2002) · NeuroImage · doi:10.1006/nimg.2002.1296 · Cited by 357
Effects of Psychotropic Drugs on Seizure Threshold
Pisani, F., Oteri, G., Costa, C., Di Raimondo, G., & Di Perri, R. (2002) · Drug Safety · doi:10.2165/00002018-200225020-00004 · Cited by 352
Frazier, C. J., Buhler, A. V., Weiner, J. L., & Dunwiddie, T. V. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08228.1998 · Cited by 327
Pickar, D. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070059008 · Cited by 318
Structural Evaluation of the Prefrontal Cortex in Schizophrenia
Buchanan, R. W., Vladar, K., Barta, P. E., & Pearlson, G. D. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.8.1049 · Cited by 314
Ichikawa, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00312-8 · Cited by 248
Low- and Conventional-Dose Maintenance Therapy With Fluphenazine Decanoate: Two-Year Outcome
Marder, S. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180028005 · Cited by 245
The Dutch Famine and schizophrenia spectrum disorders
Hoek, H. W., Brown, A. S., & Susser, E. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050068 · Cited by 243
Phenothiazine Effects on Psychological and Psychophysiological Dysfunction in Chronic Schizophrenics
Spohn, H. E. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770180019001 · Cited by 234
Benzodiazepines in the treatment of schizophrenia: a review and reappraisal
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.714 · Cited by 221
McGuffin, P., Riley, B., & Plomin, R. (2001) · Science · doi:10.1126/science.1057264 · Cited by 202
The Effects of Antipsychotic-Induced Hyperprolactinaemia on the Hypothalamic-Pituitary-Gonadal Axis
Smith, S., Wheeler, M. J., Murray, R., & O’Keane, V. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00002 · Cited by 202
The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone
Green, M. F., Marder, S. R., Glynn, S. M., McGurk, S. R., Wirshing, W. C., Wirshing, D. A., Liberman, R. P., & Mintz, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01370-7 · Cited by 202
Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential Association
Czobor, P., Volavka, J., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J., Cooper, T. B., Chakos, M., & Lieberman, J. A. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00003 · Cited by 185
Kane, J. M., Marder, S. R., Schooler, N. R., Wirshing, W. C., Umbricht, D., Baker, R. W., Wirshing, D. A., Safferman, A., Ganguli, R., McMeniman, M., et al. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.10.965 · Cited by 178
Smoking and therapeutic response to clozapine in patients with schizophrenia
McEvoy, J. P., Freudenreich, O., & Wilson, W. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00377-1 · Cited by 172
Norepinephrine decreases synaptic inhibition in the rat hippocampus
Madison, D. V., & Nicoll, R. A. (1988) · Brain Research · doi:10.1016/0006-8993(88)91440-0 · Cited by 167
Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol
Nordström, A.-L., Farde, L., & Halldin, C. (1992) · Psychopharmacology · doi:10.1007/bf02244811 · Cited by 160
Treatment of the schizophrenia prodrome: is it presently ethical?
Cornblatt, B. A., Lencz, T., & Kane, J. M. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00236-5 · Cited by 150
Traumatic Life Events and PTSD Among Women With Substance Use Disorders and Schizophrenia
Gearon, J. S., Kaltman, S. I., Brown, C., & Bellack, A. S. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.4.523 · Cited by 146
Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms
Levinson, D. F., Umapathy, C., & Musthaq, M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1138 · Cited by 141
Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia†
Greene, R. (2001) · Hippocampus · doi:10.1002/hipo.1072 · Cited by 140
Myocarditis Related to Clozapine Treatment
Hägg, S., Spigset, O., BAHons, A. B., & Söderström, T. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00005 · Cited by 140
Combination of Lithium Carbonate and Haloperidol in Schizo-affective Disorder
Biederman, J. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780030093009 · Cited by 136
The Mount Sinai Conference on the Pharmacotherapy of Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Davis, J. M., Kane, J. M., Lieberman, J. A., & Schooler, N. R. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006926 · Cited by 127
Childhood-Onset Schizophrenia: Premorbid and Prodromal Diagnostic and Treatment Histories
SCHAEFFER, J. L., & Ross, R. G. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200205000-00011 · Cited by 123
Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response
Conley, R. R., Tamminga, C. A., Kelly, D. L., & Richardson, C. M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00029-3 · Cited by 123
Cecil, K. M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00063-3 · Cited by 109
Obsessive-Compulsive Symptoms During Treatment With Olanzapine and Risperidone
de Haan, L., Beuk, N., Hoogenboom, B., Dingemans, P. M. A. J., & LINSZEN, D. H. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0203 · Cited by 108
Impact of Clozapine on Completed Suicide
Sernyak, M. J., Desai, R. A., Stolar, M. J., & Rosenheck, R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.931 · Cited by 105
Typical antipsychotic drugs — D2 receptor occupancy and depressive symptoms in schizophrenia
Bressan, R. A., Costa, D. C., JONES, H. M., Ell, P. J., & Pilowsky, L. S. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00185-2 · Cited by 90
GABAB antagonists diminish the inhibitory gating of auditory response in the rat hippocampus
Hershman, K. M., Freedman, R., & Bickford, P. C. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11523-y · Cited by 84
Self-citationEffects of dopamine on spontaneous and evoked activity of caudate neurons
Johnson, S., Palmer, M. R., & Freedman, R. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90130-2 · Cited by 81
Self-citationSuzuki, A., Kondo, T., Otani, K., Mihara, K., Yasui-Furukori, N., Sano, A., Koshiro, K., & Kaneko, S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1714 · Cited by 80
The effects of early and sustained intervention on the long-term morbidity of schizophrenia
Wyatt, R. J., & Henter, I. D. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00014-9 · Cited by 73
A Multidose Study of Haloperidol Decanoate in the Maintenance Treatment of Schizophrenia
Kane, J. M., Davis, J. M., Schooler, N. R., Marder, S. R., Casey, D. E., Brauzer, B., Mintz, J., & Conley, R. R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.554 · Cited by 67
Gelenberg, A. J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0101 · Cited by 67
Gilmore, J. H., Tol, J. V., Kliewer, M. A., Silva, S. G., Cohen, S. B., Hertzberg, B. S., & Chescheir, N. C. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00073-5 · Cited by 64
Detecting Improvement in Quality of Life and Symptomatology in Schizophrenia
Cramer, J. A., Rosenheck, R. A., Xu, W., Henderson, W., Thomas, J. V., & Charney, D. S. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006869 · Cited by 62
Phototoxic Reactions Induced by High Doses of Chlorpromazine and Thioridazine
Satanove, A., & McIntosh, J. S. (1967) · JAMA · doi:10.1001/jama.1967.03120160075010 · Cited by 54
Increasing D2 affinity results in the loss of clozapineʼs atypical antipsychotic action
Kapur, S., MCCLELLAND, R. A., VanderSpek, S. C., Wadenberg, M.-L. G., Baker, G. B., Nóbrega, J. N., Zipursky, R. B., & Seeman, P. M. (2002) · Neuroreport · doi:10.1097/00001756-200205070-00019 · Cited by 41
Buchanan, R. W., Kreyenbuhl, J. A., ZITO, J. M., & Lehman, A. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006927 · Cited by 37
Cited by
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Identification of a serotonin/glutamate receptor complex implicated in psychosis
González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., et al. (2008) · Nature · doi:10.1038/nature06612 · Cited by 803
Ross, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M., & Coyle, J. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.015 · Cited by 686
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study
Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050599 · Cited by 619
Metadata
- Authors
- Freedman, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-30
- Volume
- 349
- Issue
- 18
- Pages
- 1738-1749
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4251169171
- Cited by
- 587
- References
- 86
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.